Valley fever solutions. Reach decision-makers at VALLEY FEVER SOLUTIONS, INC. The funders had no role in study design, data collection and interpretation, or the decision to submit work for publication. David J. Valley Fever Solutions has raised funding over 6 rounds from 3 investors. VFS is looking at new potential therapeutics. VF is a painful and debilitating orphan disease causing annually over 2,000 serious cases, 9K hospitalizations, and 150 deaths. Valley Fever Solutions seeks to respond to the increasing incidence of the disease among populations in Valley Fever Solutions (VFS) is focused first on a lead compound to eliminate Coccidioides (valley fever, VF), ready for Phase 2 trials. Use 6sense to connect with top decision-makers at Valley Fever Solutions. email format is [first_initial] [last] (ex. BROADWAY, TUCSON, Arizona, United States. varies between 5. valleyfeversolutions. He completed a dual MBA in time for VFS's first STTR Grant award of ~ $1M. Its headquarters is located at Tucson, Arizona, USA. Valley Fever Solutions - Developing peptide antifungal agent for valley fever. com) location in Arizona, United States , revenue, industry and description. Larwood is employed by Valley Fever Solutions. 3 Div. Currently the VFCE is conducting clinical trials on a new Valley Fever m ed icat io n , nikkomycin Z. Nikkomycin Z powder was provided by Valley Fever Solutions, Inc. Valley Fever Solutions, Inc. But while many existing treatments successfully inhibit fungal growth, they can also cause harm to the host’s healthy cells, resulting in side effects such as nausea, vomiting and abdominal pain. This project utilized the preclinical services program offered by the National Institute of Allergy and Infectious Diseases (NIAID). (VFS, an Arizona corporation), is developing Nikkomycin Z (NikZ) as a dramatically superior potential cure for Valley Fever. Affiliations 1 California Institute for Medical Researchgrid. (company number 14050572), 1830 E BROADWAY Blvd #124-182, TUCSON, Pima, AZ, 85719 Valley Fever Solutions News - January 13, 2020 Our CEO explains our driving inspiration. Unearth financing trends to validate and advance investment opportunities. My current · Experience: Valley Fever Solutions · Education: University of California, San Francisco · Location Valley fever’s symptoms start out much like those of the flu. 4 Division of Infectious Diseases and Geographic Medicine, Stanford University Medical School, Stanford, California, USA. Information on valuation, funding, cap tables, investors, and executives for Valley Fever Solutions. 413248. American Valley Fever Association – An informative resource and He is Chairman of the Board and a significant share-holder of Valley Fever Solutions, Inc. VALLEY FEVER SOLUTIONS | 34 seguidores en LinkedIn. Thousands in southern Arizona are getting sick, whether it is the flu, COVID-19, or even Valley Fever. (VFS, an Arizona corporation), is developing Nikkomycin Z (NikZ) as a dramatically superior therapy for Valley Fever (VF). First use will be for treatment of Summary VALLEY FEVER SOLUTIONS, INC. Investors include NIH, FDA and 1 other. VFS aims to provide a dramatically . 8, San Jose, California, USA. It operates as a Developing peptide antifungal agent for valley fever. CB Rank (Person) 766,894 Primary Job Title CEO, Founder Primary Organization Valley Fever Solutions Location Redwood City, California, United States Regions San Francisco Bay Area, Silicon Valley, West Coast Gender Male LinkedIn Discover Company Info on VALLEY FEVER SOLUTIONS, INC. Dr. Free and open company data on Arizona (US) company VALLEY FEVER SOLUTIONS, INC. The company currently specializes in the Pharmaceuticals area. In addition, patients frequently need to worry about relapses, even years later. To doctors, valley fever is a medical mystery. It’s free. Organizing around Valley Fever in Arizona 1978: Galgiani arrives in Arizona 1995: Galgiani goes on a sabbatical 1996: Valley Fever Center for Excellence created. The annual revenue of VALLEY FEVER SOLUTIONS, INC. Lead product is a therapeutic protein with broad-spectrum anti-viral properties. The most common VALLEY FEVER SOLUTIONS, INC. Galgiani has a conflict of Interest management plan submitted to the University of Arizona. is a pharmaceuticals company based out of 1830 E. Their latest funding round was of $1. with its drug pipeline, therapeutic area, technology platform, 2 literature, Drug:Nikkomycin Z, VFS-1. Larwood, Valley Fever Solutions, Tucson AZ; UC San Francisco VALLEY FEVER SOLUTIONS | 29 followers on LinkedIn. - Lusha Celestial Therapeutics USA Private Celestial Therapeutics Inc. 相关的文献（医药） 2024-10-03·Microbiology Spectrum Evaluation of nikkomycin Z with frequent oral administration in an experimental model of central nervous system These studies were funded in part by Valley Fever Solutions and a grant from Valley Fever Americas Foundation, Bakersfield, CA. Nikkomycin Z (NikZ) is fungicidal to Valley Fever (VF, coccidioidomycosis) and likely fungicidal to Candida albicans, which causes >10K US deaths annually. Valley Fever Solutions is a funded company based in Tucson (United States), founded in 2007 by David Larwood and John Galgiani. Our team’s expertise and proven track record position us at the forefront of this critical endeavor. jdoe@valleyfeversolutions. (VFS) is an Arizona-based corporation dedicated to developing Nikkomycin Z (NikZ) as a highly effective therapy for Valley Fever (VF), a debilitating orphan disease. 0M and 25M. There were no conflicts of interest. Raised funding over 5 rounds from 3 investors. Celestial Therapeutics USA Private Celestial Therapeutics Inc. com location in Usa, revenue, industry and description. We are ready to eliminate Valley Fever! | VALLEY FEVER SOLUTIONS, INC. com The search for a safer treatment Treating Valley fever usually entails attacking it at its source: the fungi Coccidioides and its airborne spores. NikZ shows promise to be in the top 5 grossing drugs in $14B sector. 相关的专利（医药） 登录后查看更多信息 2 项与 Valley Fever Solutions, Inc. is a new California biotech developing novel proteins for treatment of infectious diseases and inflammatory conditions. He completed his 2024 UCSF PhD in AI-focused antimicrobial peptide design while running major animal studies for Valley Fever Solutions. To connect with VALLEY FEVER Valley Fever Solutions: Tucson, AZ, US 2007-10-03 to present | CEO Employment Show more detail Valley fever is an infectious disease caused by the Coccidioides fungus that grows in the soil and dirt in some areas of California. The Valley Fever Center for Excellence (VFCE) promotes research, education and improved patient care. With over 60,000 people affected annually, VF causes significant pain and suffering, leading to thousands of hospitalizations and deaths. By supporting the development of NikZ, you’re not just investing in a promising treatment for Valley Fever, but also contributing to the advancement of broad-spectrum antifungal therapies that can benefit a wider population of patients suffering from many fungal infections. of Infectious Diseases and Geographic Medicine, Stanford Univ. "Cure" is a big word in human therapy, which we won't claim (very hard to prove Valley fever is an illness caused by a fungus found in the soil in many parts of California, especially the Central Valley and Central Coast. com www. Formulation targets include QD oral, IV and topical. Valley Fever Solutions: Nikkomycin-Z VFS_20_0805 FDA David Larwood, CEO, davidl@valleyfeversolutions. At Valley Fever Solutions, we are driven by a dedicated team with a shared mission: to conquer Valley Fever and develop innovative antifungal solutions. Workers who work outdoors are especially at risk if they dig or disturb soil, operate heavy machinery, or work in windy conditions without taking steps to prevent valley fever. The number of employees ranges from 25 to 100. View Valley fever solutions valleyfeversolutions. is a private company. Suppressing Coccidioidomycosis in Naturally Infected Dogs by Frequent Dosing of Nikkomycin Z David J. . VALLEY FEVER SOLUTIONS | LinkedIn‘de 35 takipçi We are ready to eliminate Valley Fever! | VALLEY FEVER SOLUTIONS, INC. The Valley Fever Center for Excellence at the University of Arizona in Tucson works closely with Valley Fever Solutions. 2 Valley Fever Solutions, Tucson, Arizona, USA. Find related and similar companies as well as employees by title and much more. 相关的临床结果 登录后查看更多信息 0 项与 Valley Fever Solutions, Inc. First use will be for treatment of Arizona Congressmen David Schweikert and Ron Barber were instrumental in helping AZBio Member Valley Fever Solutions receive Fast-Track Designation from the FDA for the potential curative anti-Valley Fever drug View Valley Fever Solutions (www. Current treatments for Valley Fever still do not help a significant fraction of patients. I look to build companies to generate jobs and make good products for people. com), which is being used by 55. And now, the fungal disease is spreading northeast, thanks to climate change. 100 项与 Valley Fever Solutions, Inc. The company works on early intervention therapies and treatments for severe cases of Valley Fever that may not be effectively treated with existing methods. work email addresses. VALLEY FEVER SOLUTIONS, INC. in Tucson, AZ, such as Contacts, Addresses, Reviews, and Registered Agent. Use the PitchBook Platform to explore the full profile. 6% of VALLEY FEVER SOLUTIONS, INC. As CEO and recently Chief Scientist of Valley Fever Solutions, I led therapeutic development from bench to kilogram scale API of an NCE new class of antifungal drug, invented improved formulations Valley Fever Solutions (VFS) is focused first on a lead compound to eliminate Coccidioides (valley fever, VF), ready for Phase 2 trials. We also have a strong relationship with the Valley Fever Americas Foundation in Bakersfield, California. 7M on 2014 . Find useful insights on Valley Fever Solutions's company details, tech stack, news alerts, competitors and more. Find their phone numbers & email addresses. For some, it can be serious and even fatal. Valley Fever Solutions is developing Nikkomycin Z (NikZ) as a dramatically superior potential cure for Valley Fever. Focus is new drugs for treating respiratory infections that have limited treatments. VF is a painful and debilitating orphan disease causing annually over 2,000 serious cases, 8K hospitalizations, and 150 deaths. Company Description Valley Fever Solutions is developing Nikkomycin Z (NikZ) as a dramatically superior potential cure for Valley Fever, a painful and debilitating orphan disease. He was Co-PI for another $6M NIH support, then found support to test his new formulations. Explore Valley Fever Solutions, Inc. Medical School, Stanford, California, USA. But this illness comes from a fungus that lives in the soil, and a few cases are serious. 3 Universidade Federal do Rio Grande, Rio Grande, Brazil.
egw xjaw oph ohatu fhbch ylmpi wcdvvp oaqms kgyc gtbla